|Bid||1.1800 x 1000|
|Ask||1.1700 x 1100|
|Day's Range||1.1301 - 1.2500|
|52 Week Range||0.7410 - 3.8500|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:
NEW YORK, NY / ACCESSWIRE / October 16, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:American Renal Associates Holdings, Inc.
MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), "The Muscle Health Company" and owner of the advanced nutrition supplement Fortetropin®, announced today that it has hired The S3 Agency (S3). The Boonton-based creative agency will be executing an integrated public relations-social media campaign designed to educate the public about the important role that muscle health plays in living well – and how Fortetropin, MYOS' proprietary bioactive formula made from fertilized egg yolk, helps build lean muscle and increase muscle recovery.